Literature DB >> 28000092

The Slippery Slope Argument in the Ethical Debate on Genetic Engineering of Humans.

Douglas Walton1.   

Abstract

This article applies tools from argumentation theory to slippery slope arguments used in current ethical debates on genetic engineering. Among the tools used are argumentation schemes, value-based argumentation, critical questions, and burden of proof. It is argued that so-called drivers such as social acceptance and rapid technological development are also important factors that need to be taken into account alongside the argumentation scheme. It is shown that the slippery slope argument is basically a reasonable (but defeasible) form of argument, but is often flawed when used in ethical debates because of failures to meet the requirements of its scheme.

Entities:  

Keywords:  Argumentation schemes; Gene editing; Genetic enhancement; Germline therapy

Mesh:

Year:  2016        PMID: 28000092     DOI: 10.1007/s11948-016-9861-3

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  4 in total

1.  Human gene therapy: down the slippery slope?

Authors:  Nils Holtug
Journal:  Bioethics       Date:  1993-10       Impact factor: 1.898

Review 2.  Human gene therapy and the slippery slope argument.

Authors:  Veikko Launis
Journal:  Med Health Care Philos       Date:  2002

3.  Debunking the slippery slope argument against human germ-line gene therapy.

Authors:  D Resnik
Journal:  J Med Philos       Date:  1994-02

4.  Can human genetic enhancement be prohibited?

Authors:  W Gardner
Journal:  J Med Philos       Date:  1995-02
  4 in total
  5 in total

1.  Gene Editing and the Slippery Slope Argument: Should We Fix the Enhancement/Therapy Distinction as the Definitive Boundary?

Authors:  Iñigo de Miguel Beriain
Journal:  Sci Eng Ethics       Date:  2018-03-21       Impact factor: 3.525

2.  Recent developments in genetics and medically-assisted reproduction: from research to clinical applications†‡.

Authors:  J C Harper; K Aittomäki; P Borry; M C Cornel; G de Wert; W Dondorp; J Geraedts; L Gianaroli; K Ketterson; I Liebaers; K Lundin; H Mertes; M Morris; G Pennings; K Sermon; C Spits; S Soini; A P A van Montfoort; A Veiga; J R Vermeesch; S Viville; M Macek
Journal:  Hum Reprod Open       Date:  2017-12-04

Review 3.  Recent developments in genetics and medically assisted reproduction: from research to clinical applications.

Authors:  J C Harper; K Aittomäki; P Borry; M C Cornel; G de Wert; W Dondorp; J Geraedts; L Gianaroli; K Ketterson; I Liebaers; K Lundin; H Mertes; M Morris; G Pennings; K Sermon; C Spits; S Soini; A P A van Montfoort; A Veiga; J R Vermeesch; S Viville; M Macek
Journal:  Eur J Hum Genet       Date:  2017-12-04       Impact factor: 4.246

4.  Is selecting better than modifying? An investigation of arguments against germline gene editing as compared to preimplantation genetic diagnosis.

Authors:  Alix Lenia V Hammerstein; Matthias Eggel; Nikola Biller-Andorno
Journal:  BMC Med Ethics       Date:  2019-11-21       Impact factor: 2.652

5.  Designing Preclinical Studies in Germline Gene Editing: Scientific and Ethical Aspects.

Authors:  Anders Nordgren
Journal:  J Bioeth Inq       Date:  2019-11-21       Impact factor: 1.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.